Literature DB >> 4039768

[Fibrinolytic activity in cutaneous lesions of hereditary hemorrhagic telangiectasia].

M Watanabe, S Hanawa, T Morishima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4039768

Source DB:  PubMed          Journal:  Nihon Hifuka Gakkai Zasshi        ISSN： 0021-499X


× No keyword cloud information.
  3 in total

1.  Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models.

Authors:  Cristina Egido-Turrión; Elisa Rossi; Claudia Ollauri-Ibáñez; María L Pérez-García; María A Sevilla; José María Bastida; José Ramón González-Porras; Alicia Rodríguez-Barbero; Carmelo Bernabeu; José M Lopez-Novoa; Miguel Pericacho
Journal:  Front Med (Lausanne)       Date:  2022-05-19

Review 2.  Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.

Authors:  Athena Kritharis; Hanny Al-Samkari; David J Kuter
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

3.  An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.

Authors:  Hanny Al-Samkari; Raj S Kasthuri; Joseph G Parambil; Hasan A Albitar; Yahya A Almodallal; Carolina Vázquez; Marcelo M Serra; Sophie Dupuis-Girod; Craig B Wilsen; Justin P McWilliams; Evan H Fountain; James R Gossage; Clifford R Weiss; Muhammad A Latif; Assaf Issachar; Meir Mei-Zahav; Mary E Meek; Miles Conrad; Josanna Rodriguez-Lopez; David J Kuter; Vivek N Iyer
Journal:  Haematologica       Date:  2021-08-01       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.